busulfan has been researched along with Leukemia, Biphenotypic, Acute in 2 studies
Leukemia, Biphenotypic, Acute: An acute leukemia exhibiting cell features characteristic of both the myeloid and lymphoid lineages and probably arising from MULTIPOTENT STEM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Comparing patients with acute myeloid leukemia/myelodysplastic syndrome versus those with acute lymphoblastic leukemia/bi-phenotypic leukemia, the 1-year overall and leukemia-free survival rates were 75±10% versus 50±13%, respectively (P=0." | 2.79 | Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial. ( Bilger, K; Blaise, D; Chevallier, P; de La Tour, RP; Delaunay, J; El-Cheikh, J; Furst, S; Guillaume, T; Labopin, M; Lioure, B; Michallet, M; Milpied, N; Mohty, M; Moreau, P; Socié, G; Tabrizi, R; Vigouroux, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chevallier, P | 1 |
| Labopin, M | 1 |
| Socié, G | 1 |
| Tabrizi, R | 1 |
| Furst, S | 1 |
| Lioure, B | 1 |
| Guillaume, T | 1 |
| Delaunay, J | 1 |
| de La Tour, RP | 1 |
| Vigouroux, S | 1 |
| El-Cheikh, J | 1 |
| Blaise, D | 1 |
| Michallet, M | 1 |
| Bilger, K | 1 |
| Milpied, N | 1 |
| Moreau, P | 1 |
| Mohty, M | 1 |
| Liu, QF | 1 |
| Fan, ZP | 1 |
| Wu, MQ | 1 |
| Sun, J | 1 |
| Wu, XL | 1 |
| Xu, D | 1 |
| Jiang, QL | 1 |
| Zhang, Y | 1 |
| Huang, F | 1 |
| Wei, YQ | 1 |
| Zhao, J | 1 |
| Yu, GP | 1 |
| Meng, FY | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Open-label, Multicenter, Non Randomized Study Evaluating the Efficacy and the Safety of Clofarabine in Combination With IV Busulfan and Thymoglobulin (CBT) as a Reduced Intensity Conditioning Regimen Prior to Allogeneic Stem Cell Transplantatio[NCT00863148] | Phase 2 | 30 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for busulfan and Leukemia, Biphenotypic, Acute
| Article | Year |
|---|---|
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.
Topics: Adenine Nucleotides; Adult; Aged; Antilymphocyte Serum; Arabinonucleosides; Busulfan; Clofarabine; D | 2014 |
1 other study available for busulfan and Leukemia, Biphenotypic, Acute
| Article | Year |
|---|---|
Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens.
Topics: Adolescent; Adult; Busulfan; Child; Cyclophosphamide; Cytarabine; Etoposide; Female; Graft vs Host D | 2013 |